
Health Care Oct 26, 2018
Nuclear Molecular is Expanding to Monitor Cancer Treatments Earlier
With over 40% of non-small cell lung cancer patients not responding to first line therapy it is critical to know sooner than later if...

With over 40% of non-small cell lung cancer patients not responding to first line therapy it is critical to know sooner than later if...